The OBBBA introduced changes to research expensing as well as the R&D Tax Credit, and industry and legislative pressures continue to reshape the environment.
The R&D Tax Credit has long been one of the most powerful innovation-driven incentives in the tax code. While the core eligibility rules and definitions of qualified research expenses (QREs) have not changed, the reporting landscape has shifted, particularly with the introduction of a detailed Section G on the redesigned Form 6765.
In his latest piece in Forbes, Dave McGuire explores why 2025 will be a pivotal tax planning year. Learn how changes under the OBBBA impact bonus depreciation, Section 174 expensing, and strategic deduction timing for businesses.
As the federal tax landscape continues to shift under the One Big Beautiful Bill Act and its ripple effects, CPAs face a critical moment: how to balance proactive planning with compliance while strengthening their advisory role.
Michigan has decoupled from Section 174A. Learn how new rules require research costs to be amortized and what this means for CPA tax compliance.
Discover how IRS Rev. Proc. 2025-28 impacts Section 174 expensing, 280C elections, and accelerated deductions — key strategies for CPAs and taxpayers.
On October 1, 2025, the IRS announced an extension for certain R&D Tax Credit reporting requirements, giving taxpayers more time to adapt to the revised Form 6765.
Host Dave McGuire sits down with R&D experts David Seibel, EA, and Garrett Duffy to unpack two major developments reshaping R&D credit planning and compliance.
Revenue Procedure 2025-28 provides long-awaited clarity for small businesses on the retroactive Section 174A election, allowing them to deduct 2024 R&E costs on their originally filed return while still amending 2022 and 2023. This guidance simplifies compliance, reduces administrative burden, and gives taxpayers greater certainty in planning for R&D expensing.
“Big Beautiful Bill” aims to reinstate the full expensing of IRC §174 expenditures beginning in 2025. This creates a unique planning opportunity for taxpayers who did not claim the R&D Tax Credit or properly amortize §174 costs during the 2022-2024 tax years.
Enter your information below to access the webinar on demand
The One Big Beautiful Bill introduced changes to research expensing as well as the R&D Tax Credit, and industry and legislative pressures continue to reshape the environment. In this session, McGuire Sponsel’s David Seibel, EA, and Tanner Niehaus, CPA, will deliver an advanced roadmap for navigating R&D Tax Credits in 2026 — including proactive planning, form updates, compliance, and audit risk all geared toward maximizing client credits while minimizing risk.
Learning Objectives:
By the end of this webinar, attendees will be able to:
-
Assess Section 174A’s impact on expensing, amortization, and transition rules
-
Navigate updated R&D reporting requirements, including Section G of Form 6765
-
Integrate R&D strategies with broader tax planning and related incentives
-
Discuss R&D elections with clients
-
Apply lessons from case studies addressing Section 174 challenges
Notice: Please look for your on demand webinar link from [email protected]. Thank you!